A Global Solution for an
individual approach
in osteoarthritis treatment

About us

Developing, manufacturing and marketing Hyaluronic Acid injectable devices

ETTSONS COMPANY: a French company founded end of 2013 in Annecy. 

Walter Langiewicz, Founder and President.

ETTSONS ACTIVITY:  on the basis of strong partnership, our company is fully dedicated in developing, manufacturing and marketing (HA) Hyaluronic Acid injectable devices.

ETTSONS RESSOURCES: working closely with experts who have been involved in Hyaluronic Acid injectable devices for more than 15 years.

ETTSONS CORE COMPETENCY: As HA specialists, ETTSONS and its partners have built a strong experience and Know-How in HA products by:

  • Developing (R&D, industrialization) 
  • Manufacturing (outsourcing, purchase, supply chain, production, quality insurance, regulatory affairs)
  • Marketing (market survey, marketing strategy, marketing events and marketing tools, benchmarking)
  • Sales (worldwide distribution network, private labels (OEM or OBL), sales training, direct sales management, customer service).

ETTSONS PHILOSOPHY: our main goal is the constant search for Safety, High Quality and Efficacy which constitute the fundamentals of our philosophy. A way of working for our PRODUCTS & SERVICE to our customers and patients; Always based on partnership.

News SOLO 120 official launch

SOLO 120 official launch

ETTSONS is pleased to officially announce the launch of its MONOSHOT = SOLO 120 120 mg of pure HA in 1 single injection of 4.8 ML Designed to treat knee OA